Based on this result, either macrophage-specific ablation of LSECtin or silencing of BTN3A3 in mice bearing human tumor xenografts can block the LSECtin-BTN3A3 axis, decreasing CSC frequency and tumor growth ultimately [146]. This evidence concerns the gene BTN3A3 and neoplasm.